Blue Matter will be sponsoring the 2026 LSX Congress USA, which will take place in Boston, Sept. 23-24.
In addition, Pankaj Oza, Managing Partner at Blue Matter, will be moderating two panel discussions there:
Panel 1:
Breaking into New Markets: Strategies for Global Biopharma Expansion
- Identifying high-growth regions and market opportunities
- Navigating regulatory landscapes and compliance challenges
- Building strategic partnerships to accelerate market entry
11:00 am, Wednesday, September 23, 2026
Panelists:
- Pankaj Oza, Managing Partner, Blue Matter (Moderator)
- Renee Agular-Lucander, CEO, Hansa Biopharma
- Mike Patten, Chief Strategy Officer, Harbour BioMed
- Suguna Rachakonda, SVP, Strategy & BD, Micro CRISPR
- Abhijit Bhatia, COO, Rakuten Medical
Panel 2:
Commercializing Rare Disease Therapies: Challenges and Opportunities
- Navigating limited patient populations and high development costs
- Building awareness and education among healthcare providers
- Leveraging orphan drug incentives and regulatory support
1:30 pm, Wednesday, September 23, 2026
Panelists:
- Pankaj Oza, Managing Partner, Blue Matter (Moderator)
- Jennifer Schranz, SVP Global Head of Rare Diseases, Ipsen
- Julie Carnis, VP, US Head of Rare Oncology, SERB Pharmaceuticals
- Christine Mikail, President, CFO, & Board Director, Neurogene
- Other panelists TBD
Learn More
